MALAT-1 has been shown to relieve the inhibitory effect of miR-34a on the expression of PD-L1 and B7-H4 on the surface immune checkpoints of triple-negative breast cancer cells, which can induce the apoptosis of NKs and cytotoxic T cells in the tumor microenvironment. Here, MALAT1 is linked to neoplasm.